Clinical Hospital Colentina Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02024022
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinical Hospital Colentina

Active Ingredients

Drugs in Phase 4 Trials (4)

magnesium citrate (1 trial)

polyethylene glycol (2 trials)

sodium picosulfate (Preopik) (1 trial)

vitamin c (1 trial)

Drugs in Other Trials (1)

azithromycin (zithromax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5